AbCellera Biologics Inc. 10-Q filing
Filed 2026-05-11 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001703057-26-000028
- Form type
- 10-Q
- CIK
- 0001703057
- Primary document
- https://www.sec.gov/Archives/edgar/data/1703057/000170305726000028/abcl-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for AbCellera Biologics Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $8.3M | - | - |
| Operating Income | $-57.5M | - | - |
| Net Income | $-43.2M | - | - |
| Eps Basic | -0.14 | - | - |
| Eps Diluted | -0.14 | - | - |
| Cash And Equivalents | $77.1M | - | - |
| Total Assets | $1.3B | - | - |
| Total Liabilities | $369.0M | - | - |
| Shareholders Equity | $938.1M | - | - |
| Operating Cash Flow | $-33.5M | - | - |
| Capital Expenditures | $3.8M | - | - |